The role of IGFBP7 in promoting TAM polarization via the FGF2/FGFR1/PI3K/AKT pathway underscores the importance of targeting this pathway to disrupt the immunosuppressive TME and improve therapeutic responses in GC. The gene discussed is PIK3CB; the disease is gastric cancer.